The legacy gift from the late Shirley Jean Lane launches the next phase for HHF’s planned giving efforts: a new matching challenge to inspire legacy commitments from our community.
Meet the 2026 Emerging Research Grants Scientists
Why Early Hearing Care Matters for Your Brain
As we observe World Alzheimer’s Month each September, it’s a timely reminder that protecting our brain health starts long before memory problems arise.
Neuroscientist A. James Hudspeth, M.D., Ph.D., Has Died
At the time of his death, Hudspeth was pursuing new approaches to restoring hearing through hair cell regeneration, and his lab had recently published work demonstrating the first method for keeping a mammalian cochlea alive outside of the body—an innovation that will provide future researchers with an unprecedented means for studying the cochlea’s live biomechanics.
Auracast Landscape Expands
In Memoriam: George A. Gates, M.D., 1935–2025
George Arthur Gates, M.D., the inaugural medical director of Hearing Health Foundation’s Hearing Restoration Project (HRP), passed away on February 8, 2025.
Advancing Research and Treatment for Ménière’s Disease
While significant challenges remain, ongoing efforts in genetic research, immunology, and clinical trials offer hope for better management and potential cures for Ménière’s disease in the future.
Thank YOU Tuesday
Today, we want to extend a heartfelt THANK YOU to you and all our supporters who inspire us to push for scientific advancements.
Emerging Research Grants: Call for Applications
The Emerging Research Grants program is a competitive process that awards grants to only the most promising investigators. Recipients are exceptionally well-positioned to secure subsequent funding from major federal funders. In fact, ERG awardees (2002–present) have gone on to be awarded an average of $59 in federal research funding for every dollar of their ERG grant.
Ménière’s Disease Symposium at ARO in February
The symposium aims to spur collaborative thinking and projects among Ménière’s disease researchers and clinicians to stimulate advances in better understanding and treating Ménière's disease